Neutrophils and the calcium-binding protein MRP-14 mediate carrageenan-induced antinociception in mice

Mediators of Inflammation

Volumn 11, Issue 4, 2002, Pages 203-210

  Pagano, Rosana L ^a   Dias, Maria Angela Amorim ^b   Dale, Camila S ^a   Giorgi, Renata ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antinociception; Carrageenan; Mice; MRP 14; Neutrophils

Indexed keywords

CALCIUM BINDING PROTEIN; CALGRANULIN; CARRAGEENAN; GLUCOCORTICOID; GLYCOGEN; METYRAPONE; MONOCLONAL ANTIBODY; NALOXONE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NOCICEPTION; NONHUMAN; PERITONEUM EXUDATE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANALGESIA; ANIMALS; ANTIBODIES, MONOCLONAL; CALGRANULIN B; CARRAGEENAN; CELL MOVEMENT; ENDORPHINS; GLUCOCORTICOIDS; MALE; MICE; NEUTROPHILS;

ANIMALIA;

EID: 0036699398     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/0962935029000050     Document Type: Article

References (54)

1. Beekhuizen H, van Furth R. Monocyte adherence to human endothelium. J Leuk Biol 1993; 54: 363-78.
2. Downey GP, Fialkow L, Fukushima T. Initial interaction of leukocytes within the microvasculature: deformability, adhesion, and transmigration. New Horiz 1995; 3: 219-28.
3. Roth J, Sunderkotter C, Goebeler M, Gutwald J, Sorg C. Expression of the calcium-binding proteins MRP8 and MRP14 by early infiltrating cells in experimental contact dermatitis. Int Arch Allergy Apll Immunol 1992; 98: 140-5.
4. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C. Two calcium-biding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987; 330: 80-2.
5. 2+-binding proteins of neutrophils and monocytes. J Leuk Biol 1993; 53: 197-204.
6. Kligman D, Hilt DC. The S100 protein family. TIBS 1988; 13: 437-43.
7. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990; 336: 763-5.
8. Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983; 134: 1-6.
9. Andersson KB, Sletten K, Berntzen HB, Dale I, Brandtzaeg P, Jellum E, Fagerhol MK. The leukocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 1988; 28: 241-5.
10. Wilkinson MM, Busutti A, Hayward C, Brock DJ, Dorin JR, van Heyningen V. Expression pattern of two related cystic fibrosis-associated calcium binding proteins in normal and abnormal tissues. J Cell Sci 1988; 91: 221-30.
11. Kelly SE, Jones DB, Fleming S. Calgranulin expression in inflammatory dermatoses. J Pathol 1989; 159: 17-21.
12. Hogg N, Allen C, Edgeworth J. Monoclonal antibody 5.5 reacts with p8, 14, a myeloid molecule associated with some vascular endothelium. Eur J Immunol 1989; 19: 1053-61.
13. Dorin JR, Novak M, Hill RE, Brock DJH, Secher DS, van Heyningen V. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 1987; 326: 614-7.
14. Zwadlo G, Bruggen J, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 1988; 72: 510-5.
15. Lagasse E, Clerc RG. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol 1988; 8: 2402-10.
16. Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N. Identification of p8, 14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 1991; 266: 7706-13.
17. Roth J, Burwinkel F, van den Bos C, Goebeler M, Vollmer E, Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993; 82: 1875-83.
18. 2+-dependent translocation from cytoplasm to membranes and cytoskeleton. J Immunol 1996; 156: 1247-54.
19. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997; 272: 9496-502.
20. Nacken W, Sopalla C, Propper C, Sorg C, Kerkhoff C. Biochemical characterization of the murine S100A9 (MRP14) protein suggests that it is functionally equivalent to its human counterpart despite its low degree of sequence homology. Eur J Biochem 2000; 267: 560-5.
21. 2+-binding proteins MRP8 and MRP14 binds arachidonic acid. FEBS 1997; 408: 81-4.
22. Siegenthaler G, Roulin K, Chatellard-Gruaz D, Hotz R, Saurat JH, Hellman U, Hagens G. A heterocomplex formed by the calcium-binding proteins MRP8 (S100A8) and MRP14 (S100A9) binds unsaturated fatty acids with high affinity. J Biol Chem 1997; 272: 9371-7.
23. Newton RA, Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 1998; 160: 1427-35.
24. Sorg C. The calcium binding proteins MRP8 and MRP14 in acute and chronic inflammation. Behring Inst Mitt 1992; 91: 126-37.
25. Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994; 21: 733-8.
26. Golden BE, Clohessy PA, Russell G, Fagerhol MK. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child 1996; 74: 136-9.
27. Brun JG, Haland G, Haga HJ, Fagerhol MK, Jonsson R. Effects of calprotectin in avridine-induced arthritis. APMIS 1995; 103: 233-40.
28. Aguiar-Passeti T, Postol E, Sorg C, Mariano M. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J Leuk Biol 1997; 62: 852-8.
29. McColl SR, Showell HJ. Neutrophil-derived inflammatory mediators. In: Hellewell PG, Williams TJ, editors. Immunopharmacology of Neutrophils, Academic Press; 1994. p. 95-114.
30. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992; 13: 169-72.
31. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16: 21-6.
32. Ferreira SH. Are macrophages the body's alarm cells? Agents Actions 1980; 10: 229-30.
33. Takemura R, Werb Z. Secretary products of macrophages and their physiological functions. Am J Physiol 1984; 246: C1-9.
34. Thomazzi SM, Ribeiro RA, Campos DI, Cunha FQ, Ferreira SH. Tumor necrosis factor, interlukin-1 and interleukin-8 mediate the nociceptive activity of the supernatant of LPS-stimulated macrophages. Med Inflamm 1997; 6: 195-200.
35. Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH, Cunha FQ. involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000; 387: 111-8.
36. Dray A, Bevan S. Inflammation and hyperalgesia: highlighting the team effort. TIPS 1993; 14: 287-90.
37. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995; 75: 125-31.
38. Cunha FQ, Poole S, Lorenzetti BB, Veiga FH, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interlukin-4. Br J Pharmacol 1999; 126: 45-50.
39. Poole S, Cunha FQ, Selkirk S, Lorenzetti BB, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 1995; 115: 684-8.
40. Lorenzetti BB, Poole S, Veiga FH, Cunha FQ, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-13. Eur Cytokine Netw 2001; 12: 260-7.
41. Giorgi R, Pagano R, Amorim Dias MA, Aguiar-Passseti T, Sorg C, Mariano M. Antinociceptive effect of calcium-binding protein MRP-14 and the role played by neutrophils on the control of inflammatory pain. J Leuk Biol 1998; 64: 214-20.
42. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10.
43. Koster R, Anderson M, de Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959; 18: 412.
44. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 1993; 151: 2399-408.
45. Temple TE, Liddle GW. Inhibitors of adrenal steroids biosynthesis. Annu Ver Pharmacol Toxicol 1970; 10: 199-218.
46. Sannomiya P, Anteghini HJ, Vianna ES, Garcia-Leme J. Involvement of lymphocytes in non-immune inflammation: dual effect of glucocorticoids. Agents Actions 1985; 16: 552-7.
47. Snedecor GW,. Statistical Methods. 4th ed. Ames, Iowa, State University Press, 1974.
48. Duncan DB. Multiple range and multiple F tests. Biometrics 1955; 11: 1-42.
49. Czlonkowski A, Stein C, Herz A. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur J Pharmacol 1993; 242: 229-35.
50. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995; 332: 1685-90.
51. Garcia Leme J, Schapoval EES. Stimulation of the hypothalamo-pituitary-adrenal axis by compounds formed in inflamed tissue. Br J Pharmac 1975; 53: 75-83.
52. Garcia Leme J, Farsky SP. Hormonal control of inflammatory responses. Med Inflamm 1993; 2: 181-98.
53. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-62.
54. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones, In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 10nd ed. New York, Mc Graw Hill; 2001. p. 1649-77.